Literature DB >> 8056039

Cytokine synthesis analyzed at the single-cell level before and after revaccination with tetanus toxoid.

V Fernandez1, J Andersson, U Andersson, M Troye-Blomberg.   

Abstract

Tetanus toxoid (TT) is a potent immunogen which evokes strong antibody responses after immunization. Here, TT was used as a model antigen to study the production of cytokines at the single-cell level during the in vitro immune response to a specific recall antigen. Peripheral blood mononuclear cells were obtained from healthy volunteers before and 9 weeks after TT vaccination and were cultured with antigen in vitro. The kinetics of cytokine synthesis as well as frequencies of cytokine-producing cells were determined at the single-cell level by immunofluorescent intracellular staining of the cytokine protein. The phenotype of the producer cells was revealed by concomitant staining of surface markers. Two patterns of cytokine synthesis were induced by TT: (i) T lymphocytes expressed a number of lymphokines (interleukin (IL)-2, IL-3, IL-4, IL-10, interferon (IFN)-gamma and tumor necrosis factor (TNF)-beta), each with distinct kinetics of synthesis. This cytokine expression was strictly dependent on the previous exposure of the donor to TT and positively correlated with the level of tetanus immunity, as judged by TT-specific Ab levels in plasma as well as lymphoproliferation. Cells producing IL-2, IFN-gamma and particularly TNF-beta dominated this in vitro response. After 96-120 h in culture, 1.0-1.3% of the cells produced TNF-beta, i.e. frequencies at least tenfold higher than for any of the other lymphokines assayed. The addition of IL-2 to the cultures caused a fourfold increase and a kinetics shift in the production of TNF-beta, which peaked already at 24 h. Exogenously added IL-2 also caused a five- to tenfold increase in the number of IL-2 and IFN-gamma producers but no apparent change in the kinetics of intracellular lymphokine appearance. (ii) The cytokines IL-1 alpha, IL-1 beta, IL-6 and TNF-alpha were produced by monocytes. This inflammatory monokine response was independent of the TT-specific immune status of the donors, characterized by a rapid onset and was transient.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8056039     DOI: 10.1002/eji.1830240813

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  6 in total

1.  Three-color flow cytometry detection of intracellular cytokines in peripheral blood mononuclear cells: comparative analysis of phorbol myristate acetate-ionomycin and phytohemagglutinin stimulation.

Authors:  J Baran; D Kowalczyk; M Ozóg; M Zembala
Journal:  Clin Diagn Lab Immunol       Date:  2001-03

2.  Impaired peripheral Th1 CD4+ T cell response to Escherichia coli proteins in patients with Crohn's disease and ankylosing spondylitis.

Authors:  Asgar Ergin; Uta Syrbe; Rebecca Scheer; Andreas Thiel; Thomas Adam; Konrad Büssow; Rainer Duchmann; Martin Zeitz; Joachim Sieper
Journal:  J Clin Immunol       Date:  2011-09-08       Impact factor: 8.317

3.  Sequential production of Th1 and Th2 cytokines in response to live bacillus Calmette-Guérin.

Authors:  B Sander; U Skansén-Saphir; O Damm; L Håkansson; J Andersson; U Andersson
Journal:  Immunology       Date:  1995-12       Impact factor: 7.397

4.  Neonatal BCG vaccination is associated with enhanced T-helper 1 immune responses to heterologous infant vaccines.

Authors:  Daniel H Libraty; Lei Zhang; Marcia Woda; Luz P Acosta; Anamae Obcena; Job D Brion; Rosario Z Capeding
Journal:  Trials Vaccinol       Date:  2014

5.  Sex, Age, and Ethnic Background Shape Adaptive Immune Responses Induced by the SARS-CoV-2 mRNA Vaccine.

Authors:  Jie Bai; Asako Chiba; Goh Murayama; Taiga Kuga; Naoto Tamura; Sachiko Miyake
Journal:  Front Immunol       Date:  2022-03-28       Impact factor: 7.561

6.  Vaccination Expands Antigen-Specific CD4+ Memory T Cells and Mobilizes Bystander Central Memory T Cells.

Authors:  Eleonora Li Causi; Suraj C Parikh; Lindsey Chudley; David M Layfield; Christian H Ottensmeier; Freda K Stevenson; Gianfranco Di Genova
Journal:  PLoS One       Date:  2015-09-02       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.